Please read and agree to the
terms and conditions
of this site.
I agree
Stream
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
new york blog main
new york top stories
2
×
amgen
bcma
bluebird bio
boehringer ingelheim
bristol-myers squibb
celgene
clinical trials
eli lilly
empagliflozin
europe
europe blog main
europe top stories
fda
giovanni caforio
glaxosmithkline
idecabtagene vicleucel
indiana blog main
indiana top stories
johnson & johnson
lisocabtagene maraleucel
multiple myeloma
multiple sclerosis
national top stories
new york
nick leschly
novartis
ozanimod
poseida therapeutics
slgt2 inhibitor
type 1 diabetes
type 2 diabetes
What
approval
2
×
bid
2
×
drug
fda
2
×
asks
bcma
boehringer
bristol
cell
declined
delay
detour
diabetes
eli
expand
experimental
fallen
hit
info
ingelheim
lilly
marketed
medicine’s
multiple
myeloma
myers
patients
refuses
rejects
review
short
squibb’s
therapy
type
win
Language
unset
Current search:
approval
×
fda
×
" new york top stories "
×
bid
×
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
PROCESSING
TRANSCODING
ERROR
EXTRACTING
ERROR
{{::tile.title}}